PharmaLegacy Laboratories

Overview

PharmaLegacy Laboratories is a preclinical contract research organization specializing in in vivo pharmacology and translational animal models. The company maintains over 1,500 validated animal models of disease spanning more than 100 indications across cancer, auto-immunity, inflammation, and bone disease.

Scientific Capabilities

• Animal Models: Extensive portfolio including non-human primate models and humanized rodent models, with most models available immediately for study initiation.
• Facility & Capacity: 380,000 sq ft facility with 120,000 sq ft of SPF and conventional vivarium housing 30,000 rodents and large animals; on-site capacity for up to 350 non-human primates; partnerships with three premium non-human primate centers with combined capacity for 30,000 monkeys (Cynomolgus and Rhesus).
• Concurrent Studies: Capacity to run 200 animal studies concurrently.
• Regulatory Support: Experienced in IND/IDE filings to FDA and CFDA (China) for therapeutic biologics candidates in immune disease and oncology.
• Adjacency Services: PK/PD, molecular pharmacology, and preliminary toxicology studies.
• Data Management: Electronic research data management via BioBook (IDBS, UK); FDA Part 11 compliant systems.
• New Approach Methodologies: Committed to development and utilization of NAMs to reduce animal use.

Staffing & Operations

Scientific staff average 15–20 years of pharmacology experience, with most team members retained for 5+ years. Operations follow international GLP and QA best practices. 24/7 access to PharmaLegacy representatives; web-based live video streaming enables remote monitoring worldwide.